Bruker Corporation

  • Cryoprobe 2nd-Level-Support Engineer (f/m)

    Arbeitsort CH-ZH-Faellanden
    Datum der Veröffentlichung 2 months ago(2/26/2018 3:55 AM)
    Anzahl offener Funktionen
    Regular Full-Time
  • Überblick

    As one of the world’s leading analytical instrumentation companies, Bruker covers a broad spectrum of advanced solutions in all fields of research and development. All our systems and instruments are designed to improve safety of products, accelerate time-to-market and support industries in successfully enhancing quality of life. We’ve been driving innovation in analytical instrumentation for 50 years now. Today, worldwide more than 6,000 employees are working on this permanent challenge, at over 70 locations on all continents.


    • Maintain a global hotline for service engineers and customers
    • Participation in training courses for service engineers, occasioanally in foreign countries
    • Hardware and software projects in collaboration with R&D departments
    • Evaluation and Validation of new products and software
    • Development and maintenance of manuals and technical sales documents
    • On-site troubleshooting and service of CryoProbe systems in complex cases
    • Site planning for CryoProbe systems


    • Diploma in science or engineering
    • PhD not required, but an advantage
    • Solid knowledge of MS Office products
    • Basic application knowledge of NMR spectrometers is an advantage
    • Englisch and German CEFR Level B2 or better, French advantageous
    • Willingness to travel, also overseas

    You will find perspectives in an interesting, dynamic and interdisciplinary environment and possibilities for further personal development in an international and lively company. Do you like being on the forefront of technology? Then we are looking forward to receiving your complete online application with this reference number 2018-5759.


    Please note that we only accept online applications.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed